# Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)

> **NCT06693011** · NA · RECRUITING · sponsor: **Cerus Endovascular, Inc.** · enrollment: 250 (estimated)

## Conditions studied

- Cerebral Aneurysms

## Interventions

- **DEVICE:** Contour Neurovascular System Treatment Attempt

## Key facts

- **NCT ID:** NCT06693011
- **Lead sponsor:** Cerus Endovascular, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-10
- **Primary completion:** 2028-10
- **Final completion:** 2030-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06693011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06693011, "Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial (NEXT Trial)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06693011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*